Top 5 Heal Care Stocks To Invest In 2018

Manganese is the fourth most widely used metal in the world and an essential steel-making input. Nearly 90% of manganese output is used in the steel industry but can also be used in the manufacture of fertilizers, animal food, cars and glass.

Antares Capital Management in a recent file note following a research trip to China reported that Manganese inventory has been reducing, partly due to mine and smelter closures contributed to by pollution and environmental concerns. The relationship between Manganese ore prices and China port stocks is captured in the following chart from South32 (OTCPK:SOUHY) (OTCPK:SHTLF):

Top 5 Heal Care Stocks To Invest In 2018: AxoGen, Inc.(AXGN)

Advisors’ Opinion:

  • [By Lisa Levin]

    AxoGen, Inc. (NASDAQ: AXGN) was down, falling around 10 percent to $22.42. AxoGen reported a proposed public offering of common stock.

    Commodities

Top 5 Heal Care Stocks To Invest In 2018: Bill Barrett Corporation(BBG)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Canadian Natural Resources Limited (NYSE: CNQ): Free Stock Analysis Report
     
    Cenovus Energy Inc (NYSE: CVE): Free Stock Analysis Report
     
    Bill Barrett Corporation (NYSE: BBG): Free Stock Analysis Report
     
    ConocoPhillips (NYSE: COP): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

Top 5 Heal Care Stocks To Invest In 2018: ImmunoGen, Inc.(IMGN)

Advisors’ Opinion:

  • [By Sean Williams]

    Shares of ImmunoGen (NASDAQ:IMGN), a clinical-stage biotechnology company focused on finding cures for cancer with its proprietary antibody-drug conjugate platform, were rocketing higher by 29% as of 3 p.m. EST on Friday, apparently eager to ring in the new year with a bang.

  • [By Brian Orelli]

    ImmunoGen (NASDAQ:IMGN) is up 15.6% at 3:35 p.m. EDT on no news. The stock price bump might be a carryover from yesterday’s upgrade by Leerink Partners. Or maybe it’s short-sellers buying to cover their shorts after yesterday’s move. Or maybe it’s just because it’s a biotech and the sun came up today. Who knows?

  • [By Brian Orelli]

    ImmunoGen (NASDAQ:IMGN) is up 21.8% at 1:06 p.m. EST on no apparent news. Of course, it’s a biotech, so that’s often par for the course.

    So what

    One possibility is that day traders are just doing their thing, following the momentum, which pushes the stock price higher. We’ll know in a few days if the share price returns to previous levels.

Top 5 Heal Care Stocks To Invest In 2018: SORL Auto Parts Inc.(SORL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Sorl Auto Parts, Inc. (NASDAQ: SORL) is expected to post its quarterly earnings at $0.20 per share on revenue of $55.35 million.

    Clean Diesel Technologies, Inc. (NASDAQ: CDTI) is projected to post a quarterly loss at $0.18 per share on revenue of $10.25 million.

  • [By Lisa Levin]

    Sorl Auto Parts, Inc. (NASDAQ: SORL) was down, falling around 8 percent to $3.68. Greenridge Global downgraded SORL Auto Parts from Buy to Hold.

  • [By Lisa Levin]

    Sorl Auto Parts, Inc. (NASDAQ: SORL) shares were also up, gaining 33 percent to $6.02 after the company reported strong Q1 results and raised its FY17 sales guidance.

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto

Top 5 Heal Care Stocks To Invest In 2018: Abeona Therapeutics Inc.(ABEO)

Advisors’ Opinion:

  • [By Jim Robertson]

    Small and micro cap stocks can obviously be a fickle bunch, but I sure hope all of you participated in Abeona Therapeutics Inc. (ABEO) back when we first put the idea out there in early June. What a tremendous stock this has been for all of us, and it’s not like this happens all of the time.

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap rare disease stock Abeona Therapeutics Inc (NASDAQ: ABEO):

    Abeona Therapeutics is clearly a timing trade – we think today’s something of a blowoff top, marked by a volume surge and the fact that the stock’s already peeling back from its peak; the profit-takers are already going to work. We saw a similar surge on Tuesday, and though that one didn’t end up kick-starting a pullback, it helped set up today’s reversal bar (by virtue of luring in the last of the would-be buyers). There’s just not a lot of room left for more upside.

Leave a Reply

Your email address will not be published. Required fields are marked *